Lipid lowering effect of fulvestrant in hormone-sensitive metastatic breast cancer patients

被引：0
|
作者：
Camerini, A.
Amoroso, D.
Garrone, O.
Vincenti, M.
Tartarelli, G.
Donati, S.
Valsuani, C.
Siclari, O.
Mattiot, V. Polla
Sgambato, A.
机构：
[1] Osped Versilia, Lido Di Camaiore, LU, Italy
[2] Ist Toscano Tumori, Lido Di Camaiore, LU, Italy
[3] Osped Santa Croce, Cuneo, Italy
[4] Osped Inferm Biella, Biella, Italy
[5] Univ Cattolica, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [22] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [23] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
  • [24] Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
    Lee, Ji Hyun
    Jee, Byul A.
    Kim, Jae-Hun
    Bae, Hoyoung
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kang, Minyong
    CANCERS, 2021, 13 (24)
  • [25] Use of abiraterone for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 130 - 130
  • [26] Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer Reply
    McManus, Hannah D.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3874 - +
  • [27] Prognostic impact of sarcopenia in patients with metastatic hormone-sensitive prostate cancer
    Ikeda, Takashi
    Ishihara, Hiroki
    Iizuka, Junpei
    Hashimoto, Yasunobu
    Yoshida, Kazuhiko
    Kakuta, Yoichi
    Takagi, Toshio
    Okumi, Masayoshi
    Ishida, Hideki
    Kondo, Tsunenori
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 933 - 939
  • [28] Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Armstrong, Andrew J.
    Azad, Arun A.
    Iguchi, Taro
    Szmulewitz, Russell Z.
    Petrylak, Daniel P.
    Holzbeierlein, Jeffrey
    Villers, Arnauld
    Alcaraz, Antonio
    Alekseev, Boris
    Shore, Neal D.
    Gomez-Veiga, Francisco
    Rosbrook, Brad
    Zohren, Fabian
    Yamada, Shunsuke
    Haas, Gabriel P.
    Stenzl, Arnulf
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (15) : 1616 - +
  • [29] Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer
    Borque-Fernando, A.
    Perez-Fentes, D. A.
    Rodrigo-Aliaga, M.
    Puente-Vazquez, J.
    Gomez-Iturriaga, A.
    Unda, M.
    Calleja-Hernandez, M. A.
    Cozar-Olmo, J. M.
    alvarez-Ossorio, J. L.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (10): : 703 - 717
  • [30] Diagnosis and staging of metastatic hormone-sensitive prostate cancer
    Krausewitz, Philipp
    Ritter, Manuel
    Essler, Markus
    UROLOGIE, 2023, 62 (04): : 347 - 353
12345